ARTICLE | Company News
Rutgers University, Biohaven deal
October 10, 2016 7:00 AM UTC
The university granted Biohaven development and commercialization rights to undisclosed glutamate-modulating compounds to treat cancer. Biohaven also said it will collaborate with Rutgers to develop t...